Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
ORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the...
-
Lifecore Biomedical Q4 and Transition Period 2025 Earnings Results
-
GRF partners with Alcon to launch Spanish glaucoma education resources, including the first Spanish audiobook, for Hispanic communities.
-
97% of patients who received the BIM-IOL System off all topical IOP-lowering therapy at 12-months100% of BIM-IOL System patients achieved 20/32 or better BCDVA and a mean BCDVA equivalent to 20/20...
-
Leading CIOs honored for leadership, innovation, and business impact.
-
Leading CISOs honored for leadership, enterprise security, and business impact.
-
ORLANDO, Fla., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the...
-
Biologic Innovation to Drive Global Ophthalmic Drugs Market Growth at 7.9% CAGR Through 2036, supported by anti-VEGF therapies and AI-enabled imaging.
-
Dublin, Feb. 24, 2026 (GLOBE NEWSWIRE) -- The "OTC Artificial Tears Market Key Players Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future...
-
Dublin, Feb. 24, 2026 (GLOBE NEWSWIRE) -- The "Cataract Surgery Devices Market Companies Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and...